Pre-Open Stock Movers: ObsEva SA (NASDAQ:OBSV) 74% LOWER; plans to initiate a corporate restructuring and refocus the Companys development and commercialization strategy. ObsEva...
Investing.com - Boston Scientific (NYSE:BSX) reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Boston Scientific...
Tuesday, December 21, 2021The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks,...
Boston Scientific Corporation (NYSE:BSX) BSX recently completed the acquisition of the global surgical business of energy-based medical solutions provider, Lumenis LTD from an...
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s business segments include MedSurg, Rhythm and Neuro, and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Pelvic Health. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal (GI) and pulmonary conditions. Its Urology and Pelvic Health business develops and manufactures devices to treat various urological and pelvic conditions. The Rhythm and Neuro segment include Cardiac Rhythm Management (CRM) and Electrophysiology. Its CRM develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment include Interventional Cardiology and Peripheral Interventions. Its Interventional Cardiology develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions.
|Average||48.25 (+24.04% Upside)|
|No. of Analysts||26|